E-LIB Suche - Ergebnisse für: Rieke Alten

1

What benefit–risk trade-offs are acceptable to rheumatoid a..:

Alten, Rieke ; Nieto-Gonzalez, Juan Carlos ; Jacques, Peggy...
RMD Open. 10 (2024) 1 - p. e003311 , 2024

Link: https://doi.org/10.1136/..

2

Impact of filgotinib on pain control in the phase 3 FINCH s..:

Taylor, Peter C ; Kavanaugh, Arthur ; Nash, Peter...
RMD Open. 10 (2024) 1 - p. e003839 , 2024

Link: https://doi.org/10.1136/..

3

Consensus on the definitions and descriptions of the domain..:

Décary, Simon ; de Wit, Maarten ; Naye, Florian...
Seminars in Arthritis and Rheumatism. 65 (2024) - p. 152381 , 2024

Link: https://doi.org/10.1016/..

4

E066 Baseline characteristics of patients initiating ixekiz..:

Gullick, Nicola ; Sheesh, Mohamed ; Laedermann, Cedric...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

5

Generating a list of potentially important contextual facto..:

Weinbrecht-Mischkewitz, Max ; Kamal, Midhat ; Asim, Farwa...
Seminars in Arthritis and Rheumatism. 65 (2024) - p. 152370 , 2024

Link: https://doi.org/10.1016/..

6

P112 The Impact of Filgotinib on Disease Activity Outcomes ..:

Taylor, Peter C ; Kavanaugh, Arthur ; Nash, Peter...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

7

Subcutaneous abatacept for the treatment of rheumatoid arth..:

Alten, Rieke ; Tony, Hans-Peter ; Bannert, Bettina...
Clinical Rheumatology. 42 (2023) 9 - p. 2321-2334 , 2023

Link: https://doi.org/10.1007/..

8

Baricitinib Safety for Events of Special Interest in Popula..:

Taylor, Peter C. ; Bieber, Thomas ; Alten, Rieke...
Advances in Therapy. 40 (2023) 4 - p. 1867-1883 , 2023

Link: https://doi.org/10.1007/..

9

Physical Function of RA patients Tapering Treatment—A Post ..:

Stephan, Marlene ; Tascilar, Koray ; Yalcin-Mutlu, Melek...
Journal of Clinical Medicine. 12 (2023) 11 - p. 3723 , 2023

Link: https://doi.org/10.3390/..

10

Points to consider for cost-effective use of biological and..:

van der Togt, Céleste J T ; Van den Bemt, Bart ; Aletaha, Daniel...
RMD Open. 9 (2023) 1 - p. e002898 , 2023

Link: https://doi.org/10.1136/..

11

The Adherence and Outcomes Benefits of Using a Connected, R..:

Antalfy, Attila ; Berman, Kyle ; Everitt, Claire...
Advances in Therapy. 40 (2023) 11 - p. 4758-4776 , 2023

Link: https://doi.org/10.1007/..

12

High Usability and Applicability Ratings for the New SmartC..:

Alten, Rieke ; Moss, Simon ; Hahne, Stefanie...
Rheumatology and Therapy. 10 (2023) 2 - p. 477-487 , 2023

Link: https://doi.org/10.1007/..

13

Comparative Effectiveness, Time to Discontinuation, and Pat..:

Alten, Rieke ; Burmester, Gerd R. ; Matucci-Cerinic, Marco...
Rheumatology and Therapy. 10 (2023) 6 - p. 1575-1595 , 2023

Link: https://doi.org/10.1007/..

14

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The ..:

Taylor, Peter C. ; Laedermann, Cedric ; Alten, Rieke...
Journal of Clinical Medicine. 12 (2023) 13 - p. 4527 , 2023

Link: https://doi.org/10.3390/..

15

P131 Time to Discontinuation and Effectiveness with Baricit..:

Alten, Rieke ; Burmester, Gerd R ; Matucci-Cerinic, Marco...
Rheumatology. 62 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..